ACRO Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,313	4,040	1,564	2,409	1,024	939
Market Cap Growth	127.49%	158.32%	-35.07%	135.16%	9.09%	-
Enterprise Value	4,346	3,600	1,051	2,150	691	860
Last Close Price	74.60	66.00	25.28	38.94	19.69	24.61
PS Ratio	138.88	105.62	35.36	47.18	37.07	43.02
PB Ratio	4.81	3.66	2.50	3.51	2.71	7.22
P/TBV Ratio	4.84	3.68	2.52	3.56	2.76	7.69
EV/Sales Ratio	113.60	94.11	23.75	42.11	25.01	39.40
Debt / Equity Ratio	0.01	0.01	0.03	0.03	0.03	0.10
Net Debt / Equity Ratio	-0.88	-0.88	-0.77	-0.81	-0.81	-0.38
Net Debt / EBITDA Ratio	11.83	11.83	8.30	12.76	5.27	1.05
Net Debt / FCF Ratio	15.65	15.65	6.54	8.06	6.39	1.03
Asset Turnover	0.04	0.04	0.06	0.09	0.10	0.12
Inventory Turnover	1.69	1.69	1.79	1.09	1.05	0.52
Quick Ratio	49.90	49.90	27.58	39.66	25.82	6.11
Current Ratio	51.12	51.12	28.68	41.04	27.68	9.01
Return on Equity (ROE)	-9.55%	-9.55%	-9.46%	-7.78%	-23.94%	-32.92%
Return on Assets (ROA)	-6.45%	-6.45%	-5.89%	-5.46%	-14.27%	-18.87%
Return on Capital Employed (ROCE)	-8.30%	-8.30%	-10.20%	-6.90%	-16.30%	-38.30%
Earnings Yield	-1.56%	-2.05%	-3.97%	-1.72%	-5.94%	-5.41%
FCF Yield	-1.16%	-1.53%	-4.73%	-2.88%	-4.67%	-5.13%
Buyback Yield / Dilution	-0.04%	-0.04%	-16.17%	-11.22%	-33.71%	-17.22%